Health

无声的苦难:中国大陆罕见病的认知与管理评估

July 16, 2020

Asia

July 16, 2020

Asia
Jesse Quigley Jones

Managing editor

Jesse is a managing editor for Economist Impact based in Asia, with a focus on healthcare.

Based in Hong Kong, Jesse has been working in Asia for over 10 years. Prior to the Economist Impact, he held roles in medical education, scientific publications and medical communications, working in multinational biopharmaceutical companies with a focus in vaccines and biologic medicines. Jesse has extensive experience researching and collating medical information and working with healthcare professionals and patient organisations to develop insight-driven communications programmes.

Jesse holds a BSc in Anatomy and Physiology from the University of Leeds. His editorial interests include the policy response to emerging public health issues and patient advocacy in infectious diseases.

 

在2019年11月至12月期间,经济学人智库(The Economist Intelligence Unit)访问了100名来自中国大陆的医疗机构执业人士,作为亚太地区罕见病认知与挑战分析项目的一部分。

中国大陆的受访者包括全科医生或首诊医生(44%)、专科医生(36%)、护士(6%)和药剂师(14%)。大多数受访者在公立医院工作(74%),13%在教学医院,8%在私立医院或诊所工作。

 

Full reports:

Snapshots:

 |  |  |  | 

Video highlights:

 |  |  |  | 

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week